What is the equivalent dose of prednisolone (corticosteroid) when switching from intravenous (IV) hydrocortisone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydrocortisone to Prednisolone Conversion

When switching from intravenous hydrocortisone to oral prednisolone, use a 4:1 conversion ratio—20 mg hydrocortisone equals 5 mg prednisolone. 1, 2

Standard Conversion Ratios

The established glucocorticoid equivalency is based on anti-inflammatory potency:

  • Hydrocortisone 20 mg = Prednisolone 5 mg 1, 2
  • Prednisolone is approximately 4 times more potent than hydrocortisone 1
  • This 4:1 ratio applies to both oral and intravenous administration 2

Clinical Application by Scenario

Postoperative Transition from IV Hydrocortisone

When transitioning patients from perioperative IV hydrocortisone coverage back to oral maintenance:

  • If patient was receiving hydrocortisone 200 mg/24 hours IV (either as continuous infusion or 50 mg every 6 hours), transition to oral prednisolone at approximately 50 mg daily initially, then taper 3
  • Resume oral glucocorticoid at double the pre-surgical dose for 48 hours if recovery is uncomplicated, then return to baseline maintenance 3
  • For major surgery, continue doubled oral doses for up to one week if complications arise 3

Maintenance Therapy Conversion

For patients on chronic hydrocortisone replacement being switched to prednisolone:

  • Hydrocortisone 20 mg daily = Prednisolone 5 mg daily 1, 2
  • Hydrocortisone 30 mg daily = Prednisolone 7.5 mg daily 1, 2
  • Mean prednisolone dose for adequate adrenal replacement is approximately 3.86 mg daily (range 3-6 mg) 4, 5, 6

Acute Severe Conditions (e.g., Ulcerative Colitis)

When converting from IV hydrocortisone to oral prednisolone in acute illness:

  • Hydrocortisone 100 mg IV four times daily (400 mg/day) = Methylprednisolone 60-80 mg daily = Prednisolone 60-80 mg daily 3
  • Once patient tolerates oral intake and shows clinical improvement, switch directly to oral prednisolone at equivalent dosing 3

Important Clinical Considerations

Dosing Schedule Differences

  • Prednisolone can be given once daily in the morning, unlike hydrocortisone which typically requires 2-3 divided doses 4, 5, 7
  • Single daily dosing with prednisolone provides more convenient administration but less physiologic cortisol rhythm mimicry 5
  • Splitting prednisolone doses substantially increases total glucocorticoid exposure and should be avoided unless specifically indicated 5

Bioavailability and Timing

  • Prednisolone reaches peak concentration (Tmax) at approximately 1.4 hours after oral administration 5
  • The pharmacokinetic profile of once-daily prednisolone is similar to dual-release hydrocortisone formulations 5
  • IV to oral conversion assumes 100% bioavailability for both routes when using standard equivalency ratios 2, 8

Common Pitfalls to Avoid

Do not use higher prednisolone doses than necessary—research shows that when switching from prednisolone to modified-release hydrocortisone, the median hydrocortisone-equivalent dose decreased from 30 mg/day to 20 mg/day over 18 months, suggesting many patients on prednisolone are over-replaced 4

Monitor for cardiovascular risk factors—prednisolone is associated with significantly higher total cholesterol (6.3 vs 5.4 mmol/L) and LDL cholesterol (3.9 vs 3.2 mmol/L) compared to hydrocortisone at equivalent doses 6

Ensure adequate stress dosing protocols—patients switched to prednisolone maintenance still require stress dose adjustments during illness, with adrenal crisis rates of 5.4 per 100 patient-years reported 4

Verification of Adequacy

After conversion, assess clinical and biochemical response:

  • For adrenal insufficiency: monitor for symptoms of over- or under-replacement 4, 5
  • For inflammatory conditions: verify disease control parameters (e.g., 17-OHP for CAH, inflammatory markers for IBD) 4, 7
  • Consider dose reduction over time—57% of patients achieved adequate control on ≤25 mg hydrocortisone-equivalent daily after 18 months, compared to only 27% at baseline 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.